Capricor Therapeutics, Inc.
Pharmaceutical company · San Diego, California, United States · Nasdaq: CAPR
Capricor Therapeutics, Inc. is a pharmaceutical company headquartered in San Diego, California, United States. Its shares trade on Nasdaq under the ticker CAPR. It has reported private securities offerings to the US SEC, most recently $3.7 million sold in a notice filed in 2017.
Capricor Therapeutics at a glance
What does Capricor Therapeutics do?
Private fundraising reported to the SEC
8 Form D notices; the most recent reported $3.7 million sold (2017).
Frequently asked questions about Capricor Therapeutics
Where is Capricor Therapeutics headquartered?
Capricor Therapeutics, Inc. is headquartered in San Diego, California, United States.
What does Capricor Therapeutics do?
Capricor Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Capricor Therapeutics a public company?
Yes. Capricor Therapeutics, Inc. trades on Nasdaq under the ticker CAPR.
Similar companies
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Oncternal Therapeutics, Inc.San Diego, California, United States
- Acadia Pharmaceuticals IncSan Diego, California, United States
- ViaCyte Inc.San Diego, California, United States
- Avidity Biosciences, Inc.San Diego, California, United States
- Ligand Pharmaceuticals IncSan Diego, California, United States
- Arena Pharmaceuticals IncSan Diego, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences